BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1681719)

  • 1. Thermal inactivation of different measles virus strains.
    Klamm H; Pollex G; Henning U
    Acta Virol; 1991 Apr; 35(2):200-2. PubMed ID: 1681719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic characteristics of clones derived from measles virus strain L-16.
    Shteinberg LS; Gordienko NM
    Acta Virol; 1977 Sep; 21(5):383-90. PubMed ID: 22232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR.
    Schalk JA; van den Elzen C; Ovelgönne H; Baas C; Jongen PM
    J Virol Methods; 2004 May; 117(2):179-87. PubMed ID: 15041215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameters for plaque formation in the potency assay of Japanese measles vaccines.
    Fukuda A; Sengün F; Sarpay HE; Konobe T; Saito S; Umino Y; Kohama T
    J Virol Methods; 1996 Sep; 61(1-2):1-6. PubMed ID: 8882932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 7. Thermostability of poliovirus and measles vaccines.
    Melnick JL
    Dev Biol Stand; 1996; 87():155-60. PubMed ID: 8854012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay.
    Schlehuber LD; McFadyen IJ; Shu Y; Carignan J; Duprex WP; Forsyth WR; Ho JH; Kitsos CM; Lee GY; Levinson DA; Lucier SC; Moore CB; Nguyen NT; Ramos J; Weinstock BA; Zhang J; Monagle JA; Gardner CR; Alvarez JC
    Vaccine; 2011 Jul; 29(31):5031-9. PubMed ID: 21616113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immunosuppression on morphological changes in CNS of monkeys infected with different measles virus vaccine strains.
    Sharova OK; Rozina EE; Gordienko NM; Shteinberg LS
    Acta Virol; 1984 Mar; 28(2):144-7. PubMed ID: 6145348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Titration and stability tests for antimeasles vaccine].
    Ayala-González M
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):512-5. PubMed ID: 2206418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation and characterisation of Edmonston-Zagreb measles virus.
    Ikić D; Juzbasić M; Beck M; Hrabar A; Cimbur-Schreiber T
    Ann Immunol Hung; 1972; 16(0):175-81. PubMed ID: 4679646
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
    Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strains of measles vaccine differ in their ability to replicate in an damage human thymus.
    Valsamakis A; Kaneshima H; Griffin DE
    J Infect Dis; 2001 Feb; 183(3):498-502. PubMed ID: 11133383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal and ultraviolet inactivation of plaque purified measles virus clones.
    Di Stefano R; Burgio G; Ammatuna P; Sinatra A; Chiarini A
    G Batteriol Virol Immunol; 1976; 69(1-6):3-11. PubMed ID: 799600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of potency of inactivated measles virus vaccine by the antibody-combining test.
    Toyoshima K; Kitawaki T; Otsu K
    Biken J; 1966 Jun; 9(2):103-6. PubMed ID: 5913577
    [No Abstract]   [Full Text] [Related]  

  • 18. Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay.
    Schalk JA; de Vries CG; Jongen PM
    Biologicals; 2005 Jun; 33(2):71-9. PubMed ID: 15939284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of antibody response by temperature-sensitive measles vaccine strain in the cotton rat model.
    Haga T; Murayama N; Shimizu Y; Saito A; Sakamoto T; Morita T; Komase K; Nakayama T; Uchida K; Katayama T; Shinohara A; Koshimoto C; Sato H; Miyata H; Katahira K; Goto Y
    Comp Immunol Microbiol Infect Dis; 2009 Sep; 32(5):395-406. PubMed ID: 18249443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
    Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.